Cargando…
EGFR ‐plasma mutations in prognosis for non‐small cell lung cancer treated with EGFR TKIs: A meta‐analysis
BACKGROUND: The plasma‐based epidermal growth factor receptor (EGFR) mutation testing is approved recently to use in clinical practice. However, it has not been used as a prognostic marker yet because of contradictory results. AIM: This meta‐analysis aims to clarify the role of the EGFR‐plasma test...
Autores principales: | Phan, Thang Thanh, Tran, Vinh Thanh, Tran, Bich‐Thu, Ho, Toan Trong, Pho, Suong Phuoc, Le, Anh Tuan, Le, Vu Thuong, Nguyen, Hang Thuy, Nguyen, Son Truong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351650/ https://www.ncbi.nlm.nih.gov/pubmed/34427045 http://dx.doi.org/10.1002/cnr2.1544 |
Ejemplares similares
-
Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer
por: Tran, Vinh Thanh, et al.
Publicado: (2020) -
EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
por: Phan, Thang Thanh, et al.
Publicado: (2019) -
The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI
por: Phan, Thang Thanh, et al.
Publicado: (2018) -
Emergence role of nucleated red blood cells in molecular response evaluation for chronic myeloid leukemia
por: Phan, Thang Thanh, et al.
Publicado: (2019) -
The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis
por: Huynh, Khanh Quang, et al.
Publicado: (2023)